MMC vs VCYT · P/E 22, rev $26.98B vs P/E 47, rev $289.4M
Marsh & McLennan Companies Inc (MMC) versus Veracyte Inc (VCYT) — a side-by-side from cached financials, not a winner call.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Veracyte Inc (VCYT) is a diagnostics & research company listed on NASDAQ.
Latest reported MMC revenue for 2025-12-31 was $26.98B. Net income was $4.16B. Revenue was up 10.3% from 2024-12-31 to 2025-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Latest reported VCYT revenue for 2026-06-30 was $289.4M. Net income was $54.2M. VCYT currently screens at market cap $4.09B and trailing P/E 47.5.
MMC currently screens at market cap $89.82B and trailing P/E 21.9. VCYT currently screens at market cap $4.09B and trailing P/E 47.5.
Not investment advice. Open the MMC and VCYT stock pages for the full models.
Not investment advice.